■ Hypertrophic obstructive cardiomyopathy: the role of myectomy and percutaneous septal ablation in drug-refractory disease

Angelika Batzner, Hans-Joachim Schäfers, Konstantin V. Borisov, Hubert Seggewi

Dtsch Arztebl Int. 2019 Jan; 116(4): 47–53

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415619/

 

■ Papel da Fibrose Miocárdica na Cardiomiopatia Hipertrófica: Revisão Sistemática e Metanálise Atualizada de Marcadores de Risco para Morte Súbita

Marcelo Imbroinise Bittencourt, Samária Ali Cader, Denizar Vianna Araújo et al

Arq Bras Cardiol. 2019, vol 112(3): 281–289

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2019000300281&lng=en&nrm=iso&tlng=pt (portuguese)

 

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2019000300281&lng=en&nrm=iso&tlng=en (english)

 

■ Cardiology: hypertrophic cardiomyopathy

Medical Masterclass contributors, edited by John Firth

Clin Med (Lond) 2019 Jan; 19(1): 61–63

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399630/

 

■ Hypertrophic cardiomyopathy: genetics and clinical perspectives

Cordula Maria Wolf

Cardiovasc Diagn Ther. 2019, vol 9(Suppl 2): –S415

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837941/

 

■ Cardiomyopathy and pregnancy

Maria Schaufelberger

Heart. 2019 Oct; 105(20): 1543–1551

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839719/

 

■ Evaluating the clinical validity of hypertrophic cardiomyopathy genes

Jodie Ingles, Jennifer Goldstein, Courtney Thaxton et al

Circ Genom Precis Med. 2019, vol 12(2): e002460

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410971/

 

■ Right ventricular pacing for hypertrophic obstructive cardiomyopathy: meta-analysis and meta-regression of clinical trials

Ahran D Arnold, James P Howard, Kayla Chiew et al

Eur Heart J Qual Care Clin Outcomes. 2019, vol 5(4): 321–333

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775860/

 

■ Risk stratification in pediatric hypertrophic cardiomyopathy: insights for bridging the evidence gap?

Stephanie J. Nakano, Shaji C. Menon

Prog Pediatr Cardiol. 2018 Jun; 49: 31–37

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516538/

 

■ Apical hypertrophic cardiomyopathy: diagnosis, medical and surgical treatment

Jerzy Paluszkiewicz, Beata Krasinska, Hendrik Milting, Jan Gummert, Małgorzata Pyda

Kardiochir Torakochirurgia Pol. 2018 Dec; 15(4): 246–25

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329883/

 

■ Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therap

A J Marian, E Braunwald

Circ Res 2017, vol 121 (7): 749-770

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654557/

 

■ Hypertrophic cardiomyopathy – past, present and future

A C Liew, V S Vassiliou, C E Raphael

J Clin Med 2017, vol 6 (12): 118

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742807/

 

■  Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Estratificação de Risco Cardiovascular

Consultório: Rua Padre Rolim 815/sala 601

Tel: 33245518

CRMMG: 7026

Email: pfleite1873@gmail.com

Data: Jan 2020